Author： Johnston C.I.
Publisher： Informa Healthcare
ISSN： 1354-3784
Source： Expert Opinion on Investigational Drugs, Vol.8, Iss.5, 1999-05, pp. : 655-670
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Irbesartan: Hepatitis: case report
Reactions Weekly, Vol. 1, Iss. 1079, 2005-01 ,pp. :
Access to resources
Recommend
Drug Interactions with Irbesartan
By Marino M.R. Vachharajani N.N.
Clinical Pharmacokinetics, Vol. 40, Iss. 8, 2001-01 ,pp. :
Irbesartan vs valsartan in uncontrolled hypertension
Inpharma, Vol. 1, Iss. 1522, 2006-01 ,pp. :
Irbesartan/Hydrochlorothiazide: In Moderate to Severe Hypertension
By Croxtall Jamie D. Keating Gillian M.
Drugs, Vol. 68, Iss. 10, 2008-01 ,pp. :
Irbesartan/hydrochlorothiazide an all-INCLUSIVE antihypertensive
Inpharma, Vol. 1, Iss. 1494, 2005-01 ,pp. :